Advertisement
photo: Elizabeth A.Cummings/Shutterstock.com
photo: Elizabeth A.Cummings/Shutterstock.com

The healing or beneficial effects of some plants have long been handed down. It becomes particularly interesting when current science finds out exactly where the effect comes from and how it can then be converted into new active ingredients. Emilio Rubio and Clara Vigo report on new exiting results.

Heterotheca inuloides is locally known as Mexican arnica due to its anti-inflammatory and wound-healing traditional uses. Traditionally, it was also called “Cuateteco” and it was highly valued for its medicinal properties. 

In vitro and in vivo tests confirmed its already known anti-inflammatory and antioxidant properties and displayed a wide range of other interesting activities.

Cherishing genetic inheritance

The active ingredient which, is based on Heterotheca inuloides1, triggers multiple endogenous mechanisms of the main epidermal and dermal cells by selectively modulating the gene expression of several elements related with skin ageing.

Its broad-spectrum benefits come as a result of its remarkable multiple actions on both keratinocytes and fibroblasts, directly involved in epidermal hydration, microbiota regulation, inflammation, communication with melanocytes, cell senescence, oxidative stress, extracellular matrix and growth factors. All these actions were assessed thanks to three intense studies:

Advanced Glycation End products (AGEs) in vitro determination:

In this test, Niacinamide was used as a multifunctional reference in the market. The results of this assay showed that the active importantly (and significantly) prevented the formation of AGEs at the three tested doses (0.1%, 0.2% and 0.4%). In all cases, the anti-glycation activity was above 50%, achieving a remarkable 70.1% reduction in AGEs even at the lowest dose.

In vitro study in Normal Human Epidermal Keratinocytes (NHEK) and Fibroblasts (NHDF):

The relative quantification of gene expression was performed using real-time RT-qPCR, and results are expressed as a percentage of change over non-stimulated control, with the control expression considered to be 100%.

The results of this gene expression assessment show that the following genes’ transcription was regulated with the active: Ceramide synthase 3 (CERS3), Aquaporin 3 (AQP3), Hyaluronan synthase 1 (HAS1), Antimicrobial peptides (AMPs): β-defensin-2 (DEFB4A) and β-defensin-3 (DEFB103); Interleukin 8 (CXCL8), Endothelin 1 (EDN1), Mitochondrial transcription factor A (TFAM), Keratin 14 (KER14), Heme-Oxygenase 1 (HMOX1), Catalase (CAT), Fibroblast Growth Factor 7 (FGF7), Matrix Metalloproteinase 3 (MMP-3) and the Senescence Associated Secretory Phenotype (SASP), which entails a striking increase of pro-inflammatory cytokines: IL6, IL1β, IL8, GRO1, MCP1 and G-CSF.

Figure 1, 2, 3, 4, 5, 6. Results of the gene expression assessment, where the following genes’ transcription was regulated with the active: Ceramide synthase 3 (CERS3), Aquaporin 3 (AQP3), Hyaluronan synthase 1 (HAS1), Antimicrobial peptides (AMPs): β-defensin-2 (DEFB4A) and β-defensin-3 (DEFB103); Interleukin 8 (CXCL8), Endothelin 1 (EDN1), Mitochondrial transcription factor A (TFAM), Keratin 14 (KER14), Heme-Oxygenase 1 (HMOX1), Catalase (CAT), Fibroblast Growth Factor 7 (FGF7), Matrix Metalloproteinase 3 (MMP-3) and the senescence Associated Secretory Phenotype (SASP), which entail a striking increase of pro-inflammatory cytokines: IL6, IL1β, IL8, GRO1, MCP1 and G-CSF.

figure 1: Average face for all caucasian volunteers. Bluer tones correspond to lack of firmness and redder tones to increased firmness.
figure 1: Average face for all caucasian volunteers. Bluer tones correspond to lack of firmness and redder tones to increased firmness.

In vitro DPPH Radical Scavenging Capacity Assay:

In this test, the effect of the active ingredient was evaluated through a DPPH assay, with Vitamin C as a positive control and an antioxidant reference in the market.

The results revealed that it is able to scavenge the DPPH radical significantly. It has a remarkable dosedependent antioxidant capacity, achieving 66.6% of free radical scavenging at 2%.

Advanced Glycation End products (AGEs) in vitro determination:

In this test, Niacinamide was used as a multifunctional reference in the market. The results of this assay showed that the active importantly (and significantly) prevented the formation of AGEs at the three tested doses (0.1%, 0.2% and 0.4%). In all cases, the anti-glycation activity was above 50%, achieving a remarkable 70.1% reduction in AGEs even at the lowest dose.

Tests in vivo: Inclusive multifunctionality

All in vivo assessments were performed on a multi-ethnic panel of 71 female and male volunteers that included Caucasian, African, Asian and Latino backgrounds.

These volunteers applied a placebo-controlled formulation with 2% of the active ingredient to the hemiface, morning and night, for 56 days. Measurements were taken on D0, D14, D28 and D56.

Positive trends for all the measured parameters were already seen after only 14 days of treatment, and the improvements continued to strengthen up to D56, reaching statistical significance for all parameters (p<0.05) and empirically proving that the active not only enhances the proper functioning of the skin, but also results in visibly moisturised, smoother and firmer skin. Periocular wrinkles are visibly reduced, and the skin tone becomes more uniform. 

More specifically, the features and parameters measured include:

  • +12.8% Hydration
  • -9.3% TEWL
  • +5.9% Elasticity
  • +9.7% Firmness
  • -7.3% Wrinkles
  • -13.6% Redness
  • +22% Skin Glow

Furthermore, to better study the effect on skin firmness, the scientists were able to create – for the first time on firmness – coloured facial mapping that allowed the positive evolution of the global firming effect on the face to be visualised.

Plus, thanks to its anti-inflammatory profile, it can help prevent post-inflammatory hyperpigmentation (PIH) processes, which is an inductor of skin redness. Also by reducing skin inflammatory reactions and redness, the active will contribute to limiting inflammageing effects and therefore preventing their negative repercussion on skin ageing processes.

References

1 proliferation and differentiation of stratified epithelial cells. Molecular Biology of the Cell, 22(21), 4068–4078. https://doi.org/10.1091/mbc.E10-08-0703

2 Brandner, J. M. (2016). Importance of Tight Junctions in Relation to Skin Barrier Function. Current Problems in Dermatology (Switzerland), 49, 27–37. https://doi.org/10.1159/000441541

3 Caron, M., (2021). Celebrate diversity in the fragrance category, Mintel Insight, 2021.

4 Clark, R. A. F. (2008). Oxidative stress and “senescent” fibroblasts in non-healing wounds as potential therapeutic targets. Journal of Investigative Dermatology, 128(10), 2361–2364. https://doi.org/10.1038/jid.2008.257

5 Dai, G., Freudenberger, T., Zipper, P., Melchior, A., Grether-Beck, S., Rabausch, B., De Groot, J., Twarock, S., Hanenberg, H., Homey, B., Krutmann, J., Reifenberger, J., & Fischer, J. W. (2007). Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. American Journal of Pathology, 171(5), 1451–1461. https://doi.org/10.2353/ajpath.2007.070136

6 Delgado, G., Del Socorro Olivares, M., Chávez, M. I., Ramírez-Apan, T., Linares, E., Bye, R., & Espinosa-García, F. J. (2001). Antiinflammatory constituents from Heterotheca inuloides. Journal of Natural Products, 64(7), 861–864. https://doi.org/10.1021/np0005107

7 Dou, C., Lay, F., Ansari, A. M., Rees, D. J., Ahmed, A. K., Kovbasnjuk, O., Matsangos, A. E., Du, J., Hosseini, S. M., Steenbergen, C., Fox-Talbot, K., Tabor, A. T., Williams, J. A., Liu, L., Marti, G. P., & Harmon, J. W. (2014). Strengthening the skin with topical delivery of keratinocyte growth factor-1 using a novel DNA plasmid. Molecular Therapy, 22(4), 752–761. https://doi.org/10.1038/mt.2014.2

8 Egan, A., Bayon A., Arteaga, J., Callejas, A. (2018). A revolutionary approach, UNDP ecosystems & biodiversity. undp-biodiversity.exposure.co/a-revolutionary-approach

9 Egan, A., Bayon A., Arteaga, J., Callejas, A. (2018). Fair Share: A tool for transformation in Mexico, UNDP ecosystems & biodiversity. undp-biodiversity.exposure.co/fair-share

10 Gené, R. M., Segura, L., Adzet, T., Marin, E., & Iglesias, J. (1998). Heterotheca inuloides: Anti-inflammatory and analgesic effect. Journal of Ethnopharmacology, 60(2), 157–162. https://doi.org/10.1016/S0378-8741(97)00155-4

11 Guinaugh, O., (2020). Ingredient Trends in Beauty and Personal Care: Incl Impact of COVID-19 - US - October 2020. Mintel Report Summary, 2020. https://doi.org/10.4018/978-1-4666-4695-7.chs02

12 Hamanaka, R. B., Glasauer, A., Hoover, P., Yang, S., Blatt, H., Mullen, A. R., Getsios, S., Gottardi, C. J., Deberardinis, R. J., Robert, M., & Chandel, N. S. (2014). NIH Public Access. 6(261). https://doi.org/10.1126/scisignal.2003638

13 Humbert, P., Dréno, B., Krutmann, J., Luger, T. A., Triller, R., Meaume, S., & Seité, S. (2016). Recommendations for managing cutaneous disorders associated with advancing age. Clinical Interventions in Aging, 11, 141–148. https://doi.org/10.2147/CIA.S96232

14 Imokawa, G. (2019). Melanocyte activation mechanisms and rational therapeutic treatments of solar lentigos. International Journal of Molecular Sciences, 20(15). https://doi.org/10.3390/ijms20153666

15 Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., Agata, T., & Mizunoe, Y. (2010). Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature, 465(7296), 346–349. https://doi.org/10.1038/nature09074

16 Jonca, N. (2019). Ceramides metabolism and impaired epidermal barrier in cutaneous diseases and skin aging: Focus on the role of the enzyme PNPLA1 in the synthesis of ω-O-acylceramides and its pathophysiological involvement in some forms of congenital ichthyoses. OCL - Oilseeds and Fats, Crops and Lipids, 26(4). https://doi.org/10.1051/ocl/2019013

17 Kiatsurayanon, C., Niyonsaba, F., Smithrithee, R., Akiyama, T., Ushio, H., Hara, M., Okumura, K., Ikeda, S., & Ogawa, H. (2014). Host defense (antimicrobial) peptide, human β-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes. Journal of Investigative Dermatology, 134(8), 2163–2173. https://doi.org/10.1038/jid.2014.143

18 Kobilka, B. (2012). 基因的改变NIH Public Access. Bone, 23(1), 1–7. https://doi.org/10.1586/eem.12.34

19 Kubo, I., Kinst-Hori, I., Chaudhuri, S. K., Kubo, Y., Sánchez, Y., & Ogura, T. (2000). Flavonols from Heterotheca inuloides: Tyrosinase inhibitory activity and structural criteria. Bioorganic and Medicinal Chemistry, 8(7), 1749–1755. https://doi.org/10.1016/S0968-0896(00)00102-4

20 Kwek, S., Ling, S., (2021). 2021 global beauty & personal care trends, Mintel Trend, 2021.

21 Malaisse, J., Bourguignon, V., De Vuyst, E., Lambert De Rouvroit, C., Nikkels, A. F., Flamion, B., & Poumay, Y. (2014). Hyaluronan metabolism in human keratinocytes and atopic dermatitis skin is driven by a balance of hyaluronan synthases 1 and 3. Journal of Investigative Dermatology, 134(8), 2174–2182. https://doi.org/10.1038/jid.2014.147

22 Mangoni, M. L., Mcdermott, A. M., & Zasloff, M. (2016). Antimicrobial peptides and wound healing: Biological and therapeutic considerations. Experimental Dermatology, 25(3), 167–173. https://doi.org/10.1111/exd.12929

23 Milinazzo, A., (2021). Breaking down the cancel culture paradox, Mintel Insight, 2021.

24 Mujeres y Ambiente SPR de RL de CV, UNPD Equator Initiative, Global Programme on Nature for Development.  (2020). www.equatorinitiative.org/2020/06/04/mujeres-y-ambiente-spr-de-rl-de-cv/

25 Murase, D., Hachiya, A., Kikuchi-Onoe, M., Fullenkamp, R., Ohuchi, A., Kitahara, T., Moriwaki, S., Hase, T., & Takema, Y. (2015). Cooperation of endothelin-1 signaling with melanosomes plays a role in developing and/or maintaining human skin hyperpigmentation. Biology Open, 4(10), 1213–1221. https://doi.org/10.1242/bio.011973

26 Omedo, M.,  Kavaka W., (2018). ABS is Genetic Resources for Sustainable Development. United Nations Development Programme, 2018.

27 Palareti, G., Legnani, C., Cosmi, B., Antonucci, E., Erba, N., Poli, D., Testa, S., & Tosetto, A. (2016). Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study. International Journal of Laboratory Hematology, 38(1), 42–49. https://doi.org/10.1111/ijlh.12426

28 Patel, R., Kevin Heard, L., Chen, X., & Bollag, W. B. (2017). Aquaporins in the skin. Advances in Experimental Medicine and Biology, 969, 173–191. https://doi.org/10.1007/978-94-024-1057-0_11

29 Rodríguez-Chávez, J. L., Coballase-Urrutia, E., Nieto-Camacho, A., & Delgado-Lamas, G. (2015). Antioxidant capacity of “mexican arnica” heterotheca inuloides cass natural products and some derivatives: Their anti-inflammatory evaluation and effect on C. elegans life span. Oxidative Medicine and Cellular Longevity, 2015. https://doi.org/10.1155/2015/843237

30 Rodríguez-Chávez, J. L., Egas, V., Linares, E., Bye, R., Hernández, T., Espinosa-García, F. J., & Delgado, G. (2017). Mexican Arnica (Heterotheca inuloides Cass. Asteraceae: Astereae): Ethnomedical uses, chemical constituents and biological properties. Journal of Ethnopharmacology, 195(November), 39–63. https://doi.org/10.1016/j.jep.2016.11.021

31 Shabunin, A. S., Yudin, V. E., Dobrovolskaya, I. P., Zinovyev, E. V., Zubov, V., Ivan’kova, E. M., & Morganti, P. (2019). Composite wound dressing based on chitin/chitosan nanofibers: Processing and biomedical applications. Cosmetics, 6(1). https://doi.org/10.3390/cosmetics6010006

32 Teodoro, M., (2019). The Future of Nutrition, Health, and Wellness: 2019, Mintel Annual Report, 2019.

33 Vasileiou, P. V. S., Mourouzis, I., & Pantos, C. (2017). Principal aspects regarding the maintenance of mammalian mitochondrial genome integrity. International Journal of Molecular Sciences, 18(8). https://doi.org/10.3390/ijms18081821

34 Wang 2017 IL-1β–induced protection of Keratinocytes against S.aureus-secreted proteases is mediated by β-Defensin 2.pdf. (n.d.).

Emilio Rubio,

R&D Project Manager,

Provital, Barcelona, Spain,

www.weareprovital.com 

Clara Vigo,

Product Manager,

Provital, Barcelona, Spain,

www.weareprovital.com 

More about:

Advertisement

News Ingredients

Advertisement